Felix Dietlein

from Wikipedia, the free encyclopedia

Felix Dietlein (born June 26, 1990 in Cologne ) is a German mathematician and young scientist in the field of medicine.

Life

Dietlein is the son of the Cologne medical professor Markus Dietlein . Already as a student Dietlein began at the age of 12 years students studying computer science and mathematics at the University of Cologne . He received his diploma in mathematics at the same time as his Abitur in May 2009. This makes him the first German who completed a university degree at the same time as his Abitur (at the age of 18). He passed the Abitur at the Friedrich-Wilhelm-Gymnasium as the best of the state with a grade point average of 0.7 and 837 out of 840 possible points. During his student studies, Dietlein received a scholarship from the Deutsche Telekom Foundation .

In 2011 Dietlein received his doctorate summa cum laude with his dissertation Spectral Theoretical Structures of Coxeter Transformations Induced by Preprojective Algebras and Algebraic Combinatorics in Mathematics. In 2012 he was awarded the Klaus Liebrecht Prize for this. From 2009 to 2014 Felix Dietlein studied medicine at the University of Cologne. In 2016 he passed the second state examination in medicine. He is a postdoctoral fellow at the Clinic for Internal Medicine at the University Clinic in Cologne in the “Oncogene Signaling” working group.

In 2015, Felix Dietlein and his research team led by Christian Reinhardt succeeded in developing a new cancer therapy based on the knowledge that the growth of certain tumors can be prevented by inhibiting two enzymes (kinase inhibitors Chk1 and MK2). The results of the work were published in an article in the journal Cell , the first author of which is Dietlein. In October 2015, Dietlein received the Walter Schulz Foundation's research award for his research results, which is endowed with 10,000 euros. Dietlein is thus the youngest recipient of the Walter Schulz Foundation.

In 2016 Dietlein was awarded a doctorate by the Medical Faculty of the University of Cologne with his dissertation A framework to comprehensively identify synergistic drug interactions in cancer. nat. med. PhD.

Since the end of 2016 he has been a research assistant at the Dana-Farber Cancer Institute in Boston at Eliezer Van Allen (Harvard Medical School / Broad Institute of MIT and Harvard).

Dietlein is one of the few Germans who have three doctorates.

Awards

  • 2011: Klaus Liebrecht Prize
  • 2015: Research Award from the Walter Schulz Foundation

Individual evidence

  1. ↑ Early Studies. (pdf) (No longer available online.) Deutsche Telekom Foundation, September 2011, p. 34 , archived from the original on March 14, 2016 ; accessed on March 14, 2016 . Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. @1@ 2Template: Webachiv / IABot / www.telekom-stiftung.de
  2. ↑ D. Graalmann: gifted students. "An eager young man". In: Süddeutsche Zeitung. May 17, 2010, accessed March 14, 2016 .
  3. ↑ Education. (pdf) Ten years of the Deutsche Telekom Foundation. Deutsche Telekom Stiftung, 2013, p. 2 , accessed on March 14, 2016 .
  4. ↑ Felix Dietlein. Mathematics Genealogy Project, accessed March 14, 2016 .
  5. ↑ Dr. Felix Dietlein. (No longer available online.) Faculty of Mathematics and Natural Sciences at the University of Cologne, archived from the original on March 14, 2016 ; accessed on March 18, 2016 . Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. @1@ 2Template: Webachiv / IABot / www.uni-koeln.de
  6. ↑ Tumor Therapy: New Approaches to Stopping Cancer. (No longer available online.) Volkswagen Foundation, July 7, 2015, archived from the original on March 14, 2016 ; accessed on March 18, 2016 . Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. @1@ 2Template: Webachiv / IABot / www.volkswagenstiftung.de
  7. ↑ A Synergistic Interaction between Chk1 and MK2 inhibitor in KRAS Mutant Cancer. In: Cell. 2015, accessed on March 18, 2016 .
  8. ↑ The “Research Prize 2015” - Award ceremony. (pdf) In: Foundation letter. Walter Schulz Foundation, December 2015, p. 7 , accessed on March 18, 2016 .
  9. ↑ DNB 1108783252
  10. ↑ [1]
  11. ↑ Business card University of Cologne . klips2.uni-koeln.de. Retrieved December 27, 2019.
personal data
SURNAME Dietlein, Felix
BRIEF DESCRIPTION German mathematician and young scientist in medicine
DATE OF BIRTH June 26, 1990
PLACE OF BIRTH Cologne